NDC 79739-6094

Ascomp with Codeine

Butalbital, Aspirin, Cafeine, And Codeine Phosphate

Ascomp with Codeine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Lgm Pharma Solutions, Llc. The primary component is Butalbital; Aspirin; Caffeine; Codeine Phosphate.

Product ID79739-6094_1cab3106-1064-4b42-892b-39f405d9e02f
NDC79739-6094
Product TypeHuman Prescription Drug
Proprietary NameAscomp with Codeine
Generic NameButalbital, Aspirin, Cafeine, And Codeine Phosphate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2001-11-30
Marketing CategoryANDA / ANDA
Application NumberANDA075231
Labeler NameLGM Pharma Solutions, LLC
Substance NameBUTALBITAL; ASPIRIN; CAFFEINE; CODEINE PHOSPHATE
Active Ingredient Strength50 mg/1; mg/1; mg/1; mg/1
Pharm ClassesBarbiturates [CS],Barbiturate [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 79739-6094-1

100 CAPSULE in 1 BOTTLE (79739-6094-1)
Marketing Start Date2020-07-24
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Ascomp with Codeine" or generic name "Butalbital, Aspirin, Cafeine, And Codeine Phosphate"

NDCBrand NameGeneric Name
0722-6094Ascomp with CodeineButalbital, Aspirin, Cafeine, and Codeine Phosphate
51991-074Ascomp with CodeineButalbital, Aspirin, Caffeine and Codeine Phosphate
79739-6094Ascomp with CodeineButalbital, Aspirin, Cafeine, and Codeine Phosphate

Trademark Results [Ascomp with Codeine]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ASCOMP WITH CODEINE
ASCOMP WITH CODEINE
78225703 3179162 Live/Registered
NEXGEN PHARMA, INC.
2003-03-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.